Tilray Brands Overview
- Status
-
Public
- Employees
-
2,650

- Stock Symbol
-
TLRY

- Investments
-
30
- Share Price
-
$0.40
- (As of Friday Closing)
Tilray Brands General Information
Description
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol.
Contact Information
Website
www.tilray.comCorporate Office
- 265 Talbot Street West
- Leamington, Ontario N8H 5L4
- Canada
Corporate Office
- 265 Talbot Street West
- Leamington, Ontario N8H 5L4
- Canada
Tilray Brands Timeline
Tilray Brands Stock Performance
As of 13-Jun-2025, Tilray Brands’s stock price is $0.40. Its current market cap is $410M with 1.02B shares.
(As of Friday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$0.40 | $0.42 | $0.37 - $2.15 | $410M | 1.02B | 26.2M | -$1.10 |
Tilray Brands Financials Summary
As of 28-Feb-2025, Tilray Brands has a trailing 12-month revenue of $827M.
In Thousands, USD |
TTM 28-Feb-2025 | FY 2024 31-May-2024 | FY 2023 31-May-2023 | FY 2022 31-May-2022 |
---|---|---|---|---|
EV | 788,692 | 1,726,459 | 1,294,925 | 2,722,141 |
Revenue | 826,656 | 788,942 | 627,124 | 628,372 |
EBITDA | (785,758) | (85,674) | (1,306,445) | (258,138) |
Net Income | (945,690) | (244,981) | (1,452,656) | (476,801) |
Total Assets | 3,403,146 | 4,221,665 | 4,307,259 | 5,449,694 |
Total Debt | 343,910 | 387,317 | 590,131 | 623,806 |
Tilray Brands Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Tilray Brands Comparisons
Industry
Financing
Details
Tilray Brands Competitors (6)
One of Tilray Brands’s 6 competitors is Canopy Growth, a Formerly Accelerator/Incubator backed company based in Smiths Falls, Canada.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Canopy Growth | Formerly Accelerator/Incubator backed | Smiths Falls, Canada | ||||
Curaleaf (Biotechnology) | Formerly PE-Backed | New York, NY | ||||
Cronos Group (Pharmaceuticals) | Corporation | Toronto, Canada | ||||
Trulieve Cannabis | Corporate Backed or Acquired | Quincy, FL | ||||
Verano Holdings | Corporation | Chicago, IL |
Tilray Brands Patents
Tilray Brands Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20220347152-A1 | Cannabidiol-dominant formulations, methods of manufacturing, and uses thereof | Active | 29-Apr-2021 | ||
CA-3217137-A1 | Cannabidiol-dominant formulations, methods of manufacturing, and uses thereof | Pending | 29-Apr-2021 | ||
US-12029720-B2 | Cannabidiol-dominant formulations, methods of manufacturing, and uses thereof | Active | 29-Apr-2021 | ||
US-20240342130-A1 | Cannabidiol-dominant formulations, methods of manufacturing, and uses thereof | Pending | 29-Apr-2021 | ||
AU-2020369512-A1 | Methods of administering cannabinoid to people diagnosed with hiv | Pending | 25-Oct-2019 | A61K31/352 |
Tilray Brands Signals
Tilray Brands Investments & Acquisitions (30)
Tilray Brands’s most recent deal was a Merger/Acquisition with Atwater Brewery. The deal was made on 01-Sep-2024.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Atwater Brewery | 01-Sep-2024 | Merger/Acquisition | Beverages | ||
Hop Valley Brewing Company | 01-Sep-2024 | Merger/Acquisition | Beverages | ||
Revolver Brewing | 01-Sep-2024 | Merger/Acquisition | Beverages | ||
Terrapin Beer | 01-Sep-2024 | Merger/Acquisition | Beverages | ||
Anheuser-Busch (Eight Beer & Beverage Brands) | 02-Oct-2023 | Corporate Asset Purchase | Beverages |
Tilray Brands ESG
Risk Overview
Risk Rating
Updated August, 22, 2024
35.88 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,673
Rank
Percentile

Pharmaceuticals
Industry
of 844
Rank
Percentile

Pharmaceuticals
Subindustry
of 419
Rank
Percentile

Tilray Brands Exits (4)
Tilray Brands’s most recent exit was on 03-Aug-2023 from Truss Beverages. The exit was categorized as .
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
Truss Beverages | 03-Aug-2023 | Completed |
|
||
MedMen Enterprises | 18-Sep-2021 | Completed |
|
||
Rose Lifescience | 30-Nov-2018 | Completed |
|
||
Intelgenx Technologies | 08-May-2018 | PIPE | Completed |
Tilray Brands Affiliates
Subsidiaries (10)
Name | Industry | Location | Year Founded |
---|---|---|---|
Smith & Sinclair | London, United Kingdom | 2014 | |
Montauk Brewing Company | Montauk, NY | 2012 | |
Privateer Holdings | Seattle, WA | 2010 | |
Hop Valley Brewing Company | Eugene, OR | 2009 | |
Breckenridge Distillery | Breckenridge, CO | 2008 |
Tilray Brands FAQs
-
Where is Tilray Brands headquartered?
Tilray Brands is headquartered in Leamington, Canada.
-
What is the size of Tilray Brands?
Tilray Brands has 2,650 total employees.
-
What industry is Tilray Brands in?
Tilray Brands’s primary industry is Pharmaceuticals.
-
Is Tilray Brands a private or public company?
Tilray Brands is a Public company.
-
What is Tilray Brands’s stock symbol?
The ticker symbol for Tilray Brands is TLRY.
-
What is the current stock price of Tilray Brands?
As of 13-Jun-2025 the stock price of Tilray Brands is $0.40.
-
What is the current market cap of Tilray Brands?
The current market capitalization of Tilray Brands is $410M.
-
What is Tilray Brands’s current revenue?
The trailing twelve month revenue for Tilray Brands is $827M.
-
Who are Tilray Brands’s competitors?
Canopy Growth, Curaleaf (Biotechnology), Cronos Group (Pharmaceuticals), Trulieve Cannabis, and Verano Holdings are some of the 6 competitors of Tilray Brands.
-
What is Tilray Brands’s annual earnings per share (EPS)?
Tilray Brands’s EPS for 12 months was -$1.10.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »